Avirulent strains of poliovirus type 1 exhibit an altered VP-1 capsid polypeptide compared to the neurovirulent Mahoney strain.
Answers are grounded in this paper and cite their sources.
Suggests VP-1 alteration as attenuation marker in animal models; leaves open causal role and human relevance.
Several avirulent samples of poliovirus type 1 derived in the process attenuating the neurovirulent Mahoney strain show an altered virus capsid polypeptide, VP-1, on polyacrylamide gel electrophoresis of sodium dodecyl sulfate-disrupted virions.
No takes yet. Share an insight, caveat, or question.
Milstien et al. (1977) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: